Introduction
The role for type IV collagens in human diseases is gaining broader appreciation. The variability of diseases caused by mutations in type IV collagen genes is dictated, at least in part, by the distribution of the corresponding protein product. α1(IV) and α2(IV) are present in nearly all basement membranes in the body. Mutations in the genes encoding α1(IV) and α2(IV) were only recently identified and the full breadth of their contribution to disease remains to be discovered (Breedveld et al., 2006; de Vries et al., 2009; Favor et al., 2007; Gould et al., 2005 Gould et al., , 2006 Plaisier et al., 2007; Sibon et al., 2007; Vahedi et al., 2007a,b) . Ocular anterior dysgenesis is a highly penetrant phenotype in mice with Col4a1 or Col4a2 mutations. Mutant mice have ocular anterior segment dysgenesis (ASD) that resembles a spectrum of human phenotypes, including Axenfeld-Rieger Anomaly, which causes secondary glaucoma (Favor et al., 2007; Gould et al., 2007; Van Agtmael et al., 2005) . In the posterior eye, Col4a1 mutation causes optic nerve hypoplasia (Gould et al., 2007) and retinal degeneration (D.B. Gould unpublished results).
Mutations in genes coding for the more spatially restricted α3(IV), α4(IV), and α5(IV) cause Alport syndrome. Alport syndrome is characterized by hematuria, progressive renal impairment, high-tone sensorineural hearing loss, and ocular abnormalities. Ocular abnormalities are highly, but not completely, penetrant. Approximately 70% of patients have thin lens capsules and lenticonus (bulging of the anterior lens), and 50-80% of patients have central or peripheral retinopathy appearing as whitish-yellow dots and flecks (Barker et al., 1990; Chugh et al., 1993; Colville and Savige, 1997; Jacobs et al., 1992; Streeten et al., 1987) . Other ocular features including posterior polymorphous corneal dystrophy or macular holes are also reported in rare cases (Colville et al., 1997a) . The vast majority of Alport syndrome is X-linked and caused by mutations in COL4A5; however, ocular features do not appear to differ between X-linked and autosomal recessive cases (attributed to COL4A3 or COL4A4 mutations) (Colville et al., 1997b; Colville and Savige, 1997) . To date, mutations in COL4A6, alone, are not shown to contribute to disease but mutation of COL4A6 in combination with COL4A5 contributes to leiomyomatosis (Cochat et al., 1988; Heidet et al., 1997) .
Normal vision requires precise localization and arrangement of several distinct ocular structures. Development of these structures requires coordinated interactions between embryonic tissues, all of which interact with basement membranes. Mutations of basement membrane components lead to ocular dysgenesis; however, the mechanism(s) are unknown (Favor et al., 2007; Gould et al., 2005 Gould et al., , 2007 Semina et al., 2006; Sibon et al., 2007; Van Agtmael et al., 2005; Zenker et al., 2004 Zenker et al., , 2005 . In mice, ocular development starts around mid-embryogenesis and proceeds through a series of characteristic morphological stages (Gould et al., 2004; Kaufmann, 2005) . By birth, the major ocular structures are formed and ocular basement membranes are in place surrounding the cornea, lens, retina and vasculature ( Fig. 1) .
Basement membranes are specialized structures of extracellular matrix that play essential roles in tissue development and maintenance, and type IV collagens are abundant components of all basement membranes. Type IV collagens are a family of six proteins encoded by six distinct genes, COL4A1 through COL4A6 Hostikka and Tryggvason, 1988; Leinonen et al., 1994; Mariyama et al., 1994; Soininen et al., 1987; Zhou et al., 1994) . They are arranged on chromosomes head-to-head in pairs, with COL4A1 and COL4A2 on chromosome 13, COL4A3 and COL4A4 on chromosome 2, and COL4A5 and COL4A6 on the X chromosome (Hudson et al., 1993; Kuhn, 1995) . During assembly in the endoplasmic reticulum, three collagen IV peptides interact to form one of three triple-helical heterotrimers, α1α1α2, α3α4α5, or α5α5α6 (Borza et al., 2001; Gunwar et al., 1998; Risteli et al., 1980) . After secretion, heterotrimers make further, higher-order associations to form mesh-like collagen IV networks and integrate with other components, such as laminin, Nidogen/entactin and perlecan, to form basement membranes (Borza et al., 2001 (Borza et al., , 2002 Timpl et al., 1981) . Distribution and abundance of collagen IV heterotrimers is tissue specific and varies with developmental stages Nakano et al., 2007; Saito et al., 2000; Urabe et al., 2002) .
To better understand the mechanism(s) of collagen IV-related ocular diseases, we sought to determine the timing and distribution of . Differential distribution of type IV collagens in the developing mouse eye. Ocular distribution of collagen IV isoforms was determined using monoclonal antibodies to each isoform at advancing stages of development (the age for each row is indicated in the upper right corner of panels A-F). α1(IV) and α2(IV) always co-localized, were ubiquitously present, and are represented by α1(IV) labeling (A-F). α3(IV) and α4(IV) always co-localized, had developmentally dynamic expression, and are represented by α4(IV) labeling (G-L). α5(IV) colocalized both with α3/α4(IV) and with α6(IV) (M-R). Together α1(IV), α4(IV) and α6(IV) represent the α1α1α2, α3α4α5 and α5α5α6 heterotrimers respectively. A summary of the data can be found in Table 1 . Scale bars: E12.5-E14.5: 200 µm; E16.5-P4: 100 µm.
all six collagen IV isoforms in the developing mouse eye. The timing and location of initial protein expression defines limits for timing and location of primary pathogenesis. To date, only a single study examined the distribution of type IV collagens in the developing human or mouse eye and it focused exclusively on the lens capsule (Kelley et al., 2002) . Other reports have studied type IV collagens in the developed human eye but the distribution and timing of expression during development is currently unknown (Chen et al., 2003; Kabosova et al., 2007; Schlotzer-Schrehardt et al., 2007) . By only studying already-developed and adult organs, one could overlook important biological and disease-related processes. Equally important as stage-specific differences are species-specific differences. Distribution differences between humans and mice will be important to identify and define as mouse models are increasingly used to understand collagen IV-related human ocular diseases. Here, we define the localization of collagen IV isoforms in the developing mouse eye.
Results

Differential distribution of type IV collagens in the developing eye
To examine the distributions of all six collagen IV isoforms in developing eyes, we labeled eyes from various embryonic and postnatal stages with monoclonal antibodies against each isoform . We found that α1(IV) always co-localized with α2(IV) and that α3(IV) always co-localized with α4(IV), whereas α5(IV) colocalized both with α3(IV)/α4(IV) and with α6(IV) ( Table 1) . This is consistent with the existence of three types of heterotrimers, α1α1α2, α3α4α5 and α5α5α6. Data from α1(IV), α4(IV) and α6 (IV) were chosen to represent the three heterotrimers respectively (Fig. 2) .
α1(IV) and α2(IV) were ubiquitously expressed in all ocular basement membranes at all developmental stages tested, with the strongest labeling intensity detected in the lens capsule. α1(IV) and α2(IV) were already present at E12.5 and labeled the entire lens capsule and tunica vasculosa lentis (the vascular network immediately adjacent to the posterior surface of the lens capsule) throughout development (Figs. 2 and 3 ). Both the epithelium and endothelium of the cornea were labeled, as were the pigmented and non-pigmented epithelia of the ciliary body and the pigmented epithelia of the iris (Fig. 4) . In the iridocorneal angle, α1(IV) and α2(IV) were detected in the episcleral vein and the developing trabecular meshwork. In the vitreous and inner retina, α1(IV) and α2(IV) antibodies strongly and consistently labeled the hyaloid vasculature whereas the labeling intensity of the inner limiting membrane was weaker and decreased after E16.5 (Figs. 2 and 5). Bruch's membrane is an organized extracellular matrix structure outside the retina, with basement membranes secreted from the RPE (retinal pigment epithelium) and the vascular endothelial cells of the choriocapillaris, which define the innermost and outermost layers respectively. α1(IV) and α2(IV) both exhibited network- like labeling in Bruch's membrane, consistent with the endothelial basement membrane of the choriocapillaris (Fig. 6) . The intimate association of the RPE and choroidal basement membranes prevented unequivocal determination of labeling in the RPE basement membranes. However, high magnification confocal microscopy revealed complete co-localization with laminin, suggesting that α1(IV) and α2 (IV) were expressed both in RPE and choroidal basement membranes (data not shown). Overall, α1(IV) and α2(IV) always co-localized and were present in all basement membranes of the developing eye.
α3(IV) and α4(IV) had the most restricted distribution and underwent the most dynamic changes during ocular development. They were first detected at E14.5 as a faint labeling of Bruch's membrane at the posterior pole of the eye (Fig. 2) . By E18.5, the intensity of the signal had increased and the signal spread peripherally to include all of Bruch's membrane, implying an increase in both the level and distribution of α3(IV) and α4(IV) expression. Labeling in Bruch's membrane was unlike the network-like labeling of the choriocapillaris detected with α1(IV) and α2(IV) but instead was a single, tight line indicating the RPE basement membrane. Similar to the posterior pole of the eye, a central-to-peripheral expansion of labeling was detected in the lens capsule. Labeling was first detected in the anterior pole of the lens capsule but then spread peripherally in early postnatal eyes (Fig. 3) . By P4, the entire anterior and peripheral lens was positive for α3(IV) and α4(IV). Postnatal labeling was also detected in the corneal endothelium. In summary, localization of α3(IV) and α4(IV) was temporally dynamic and relatively restricted compared to other type IV collagen isoforms. α5(IV) and α6(IV) were present in most ocular basement membranes. α5(IV) co-localized both with α3(IV)/α4(IV) and with α6(IV) and contributes to two different heterotrimers, α3α4α5 and α5α5α6. Therefore, only α6(IV) labeling is specific to the α5α5α6 heterotrimer. α5(IV) and α6(IV) were already detected in the entire lens capsule and the inner limiting membrane at E12.5 and labeling remained throughout development. Corneal epithelium was labeled at E14.5 followed by corneal endothelial labeling at E16.5 (Fig. 2) . Relatively intense labeling was detected adjacent to the pigmented and non-pigmented epithelia of the ciliary body and throughout the iridocorneal angle with the exception of the episcleral vein, which was labeled by α1(IV) and α2(IV) (Fig. 4) . The vitreous and inner retina revealed further notable differences between α5α5α6 compared to α1α1α2. The inner limiting membrane labeled relatively stronger with α5(IV) and α6(IV); however, no labeling was observed in the hyaloid vasculature or the tunica vasculosa lentis for either α5(IV) or α6(IV) indicating that only the α1α1α2 heterotrimer is present there (Figs. 3 and 5) . A second notable difference was observed in the RPE contribution of Bruch's membrane. After transient detection of α6(IV) in the anterior and peripheral Bruch's membrane at E12.5 and E14.5, α5(IV), but not α6(IV), was detected in the basal RPE indicating that α5(IV) in Bruch's membrane is part of the α3α4α5 heterotrimer. Neither α5(IV) nor α6(IV) was present in the choriocapillaris (Fig. 6) . Taken together, α5(IV) was detected in all basement membranes except for the episcleral vein, hyaloid vasculature, tunica vasculosa lentis and choriocapillaris indicating that α1α1α2 is the only heterotrimer localized to the vasculature.
Discussion
Our data demonstrate the distribution pattern of all six collagen IV isoforms. Localization of these isoforms is consistent with formation of the three heterotrimers: α1α1α2, α3α4α5 and α5α5α6 and the results are summarized in Table 1 . Different heterotrimers are proposed to have different physical characteristics. For example, compared to α1α1α2 heterotrimers, α3α4α5 heterotrimers have a greater number of interand intra-molecular cross-links. As a result, α3α4α5 heterotrimers are predicted to be stronger and more resistant to proteolysis, while α1α1α2 heterotrimers are predicted to be more elastic and susceptible to physical or proteolytic breakdown. Others have suggested that isoform switching reflects a tissue's changing demands for mechanical strength or elasticity (Kabosova et al., 2007; Kelley et al., 2002) . While potentially correct, it is important to consider that the physical properties of the basement membranes might not be entirely dictated by the collagen network and contributions of other basement membrane proteins should be considered. Additionally, differential isoform usage may reflect not only physical properties but also other important biological properties; for example, cell-matrix interactions or differential sequestration/release of growth factors during key developmental windows. Comprehensive studies of basement membrane composition, physical properties (Candiello et al., 2007) and intracellular signaling through development, especially during times of isoform changes, will be important for understanding the significance of these events.
To better understand which cell types and basement membranes might be responsible for the pathology in collagen IV-related diseases, we paid particular attention to which heterotrimers localized to sites of pathogenesis. The lens capsule is a specialized basement membrane enveloping the entire lens, and its components are produced and secreted by lens epithelial cells. Mice with mutation of Col4a1 or Col4a2 have lens abnormalities including cataracts and lens vacuoles (Favor et al., 2007; Gould et al., 2007; Van Agtmael et al., 2005) . Similarly, Alport syndrome patients with mutations in COL4A3, COL4A4, or COL4A5 are frequently reported with cataracts, and ruptured or weakened lens capsule that results in lenticonus (Arnott et al., 1966; Colville and Savige, 1997) . Consistent with these phenotypes, all three heterotrimers are detected in the developing lens.
In addition to these cell autonomous defects, the lens is important for normal development of the ocular anterior segment. Dysgenesis of the anterior segment, and specifically the ocular drainage structures in the iridocorneal angle strongly predispose to elevated intraocular pressure and glaucoma. Glaucoma is one of leading causes of blindness and is often associated with elevated intraocular pressure. Col4a1 mutant mice have anterior segment dysgenesis and elevated intraocular pressure (Gould et al., 2007) , which model human developmental glaucoma. Recently a COL4A1 mutation was identified in a family with anterior segment dysgenesis (Axenfeld-Reiger Anomaly) and glaucoma (Sibon et al., 2007) . One possibility is that anterior segment dysgenesis is secondary to primary lens defects. Co14a1 mutation causes endoplasmic reticulum stress in lens epithelial cells (Gould et al., 2007) , which might influence production or secretion of growth factors. Alternatively, structural differences in mutant lens capsules could lead to aberrant sequestration or release of important signaling molecules (Neptune et al., 2003; Wang et al., 2008) . Absence of anterior segment dysgenesis and glaucoma in Alport patients might suggest that the timing of the lens defects is important, the mechanism is different (either functional defects in lens epithelium or structural defects of lens capsule) or that the lens is not the primary site of pathogenesis. The presence of α1α1α2, but not α3α4α5 heterotrimer, in the developing iridocorneal angle might suggest that iridocorneal angle, and not the lens, is a primary site of pathogenesis. Understanding the location of the primary insult will greatly facilitate identification of the underlying cellular mechanism. We have developed a Col4a1 conditional mutant allele that will enable us to test the effect of the mutant protein when expressed in a tissue specific manner.
In the retina, developmental or progressive loss of retinal ganglion cells can contribute to optic nerve hypoplasia or glaucoma respectively. The inner limiting membrane is adjacent to retinal ganglion cells and is important for retinal ganglion cell survival during development (Halfter et al., 2005) . Col4a1 mutant mice have inner limiting membrane abnormalities, and increased loss of retinal ganglion cells during development appears to contribute to optic nerve hypoplasia (D. J. Dilworth manuscript in preparation). Although currently untested, inner limiting membrane abnormalities could also give rise to retinal ganglion cell death in response to elevated intraocular pressure, and thus predispose to glaucoma. The signal intensity of α1α1α2 in the inner limiting membrane decreased with age and α5α5α6 appeared to be the predominant heterotrimer postnatally (Fig. 2) . This suggests that α1α1α2 might be important during development but that α5α5α6 might be more important in the mature inner limiting membrane.
Bruch's membrane is an important anatomical structure for retinal diseases and has two distinct basement membranes. The innermost layer of Bruch's membrane is a basal lamina secreted by the RPE cells and the outermost layer is a basal lamina secreted by the vascular endothelium of the choriocapillaris. Similar to the distribution in human Bruch's membrane (Chen et al., 2003) , α1α1α2 is the only heterotrimer present in the choroidal vasculature, and α3α4α5 molecules are present in the RPE basement membrane. Most Alport syndrome patients have dot-and-fleck retinopathy, however, little is known about the pathogenic mechanisms. Depending on genetic context, Col4a1 mutant mice have clinical, histological and molecular similarities to human patients with age-related macular degeneration (D. B. Gould manuscript in preparation). Macular degeneration is the leading cause of blindness in the elderly. Understanding both the cellular mechanism(s) and the relative contribution of RPE versus choroidal vasculature to diseases could provide important insights into prevention and treatment of this common cause of blindness.
Here, we examined the differential localization of type IV collagens during ocular development with special attention to sites relevant for human ocular diseases. Understanding the timing and localization of different isoforms will help elucidate mechanism(s) of ocular diseases caused by collagen IV mutations. Using this comprehensive and detailed analysis as a template, we will further refine the primary site (s) of Col4a1-related ocular pathology using tissue specific expression of a conditional mutant allele. These studies have direct relevance to several developmental and progressive diseases including optic nerve hypoplasia, glaucoma, and macular degeneration that collectively contribute to vision loss in millions of patients worldwide.
Experimental procedures
Tissue preparation
All animals used in this study were inbred derivations of C57BL/6J mice obtained from the Jackson Laboratory (Bar Harbor, ME). All experiments conducted were in accordance with the Institutional Animal Care and Use Committee guidelines. Two reference points were used to determine developmental stage: for embryonic samples, the time when a vaginal plug was observed was designated as embryonic day 0.5 (E0.5); for postnatal samples, the date of birth was designated as postnatal day 0 (P0). Embryos at E12.5, E14.5, E16.5 and E18.5 were harvested from timed pregnant females. For both embryonic and postnatal samples, heads were quickly excised, washed 3 times in cold PBS and incubated in 4% sucrose for 4 h. Samples were then embedded in OCT compound (Sakura Finetek USA Inc. Torrance, CA) and frozen with dry-ice/ethanol bath and stored at − 20°C. All tissue sections were obtained by cryosectioning in the horizontal plane at a thickness of 8-10 μm using a Leica CM1900 cryostat (Rankin Biomedical Corp. Holly, MI).
Hematoxylin & eosin staining
Cryosections were fixed in 100% ethanol for 10 min, incubated in hematoxylin (Richard-Allan Scientific, Kalamazoo, MI) for 2 min. Samples were then washed sequentially in H 2 O for 30 s, Clarifier I (Richard-Allan Scientific, Kalamazoo, MI) for 1 min, H 2 O for 1 min, Bluing Reagent (Richard-Allan Scientific, Kalamazoo, MI) for 1 min, H 2 O for 1 min and finally 95% ethanol for 30 s The sections were counterstained with eosin Y (Fisher Scientific, Fair Lawn, NJ) for 2.5 min, washed two times each in 100% ethanol and xylene, and then cover slipped using Permount mounting media (Fisher Scientific, Fair Lawn, NJ). Images were obtained using an AxioImager M1 microscope equipped with an AxioCam ICc3 color digital camera and AxioVision software (Zeiss, Germany). Post-acquisition images were processed in Photoshop CS3 (Adobe).
Immunohistochemistry
Cryosections were fixed in acetone for 10 min, rinsed briefly with TT buffer (50 mM Tris-HCl, pH 7.4, 0.1% Tween 20) and then subjected to two different antigen retrieval methods. All antibodies gave consistent labeling with both antigen retrieval methods and so we proceeded with the method that gave the best signal-to-noise ratio for each antibody. For retrieval of α1(IV), α2(IV) and α5(IV) antigens, sections were incubated in acid solution (0.1 M KCl/HCl, pH1.5) for 10 min. For retrieval of α3(IV), α4(IV) and α6(IV) antigens, sections were incubated for 20 min in 6 M urea containing 0.1 M glycine (pH3.5). After antigen retrieval, sections were washed 3 times in TT buffer, incubated for 1 h in blocking buffer (10% normal goat serum and 2 mg/ml bovine serum albumin in Tris buffer), and then incubated for 2 h in TT buffer containing rabbit anti-laminin antibody (dilution 1:2000, Abcam Inc, MA) and/or collagen α(IV) chain-specific antibody: H11 (dilution 1:200), H22 (dilution 1:20), H31 (dilution 1:50), RH42 (dilution 1:100), H53 (dilution 1:100), B66 (dilution 1:50) (Shigei Medical Research Institute, Japan). After washing three times with TT buffer, samples were incubated in a dark, humid chamber for 40 min with appropriate secondary antibodies: Alexa Fluor 594 anti-rabbit IgG for laminin or Alexa Fluor 488 anti-rat IgG for collagen IV antibodies (dilution 1:2000, Molecular Probes, OR). Samples were washed three times with TT buffer and cover slipped with Vectashield Hardset mounting media with DAPI (Vector Laboratories Inc. CA). Images were captured using either a LSM5 PASCAL confocal microscope with Neofluor objective lens, or an AxioImager M1 microscope equipped with an AxioCam MRm digital camera and AxioVision software (Zeiss, Germany). Post-acquisition images were processed in Photoshop CS3 (Adobe).
Antibodies
Monoclonal antibodies against each of the six collagen IV isoforms were purchased from Shigei Medical Research Institute (Japan) and have been described previously . Briefly, rats or mice were immunized with synthetic peptides to collagen IV NCI or the triple helical domain. Lymphocytes from the immunized animals were harvested and fused with mouse myeloma cells. Supernatants from hybridoma cultures were screened with ELISA and indirect immunofluorescence. We tested ten antibodies: one each for α1(IV) and α3(IV) and two each for α2(IV), α4(IV), α5(IV) and α6(IV). Where two antibodies were available for a protein, data were always consistent and we chose the antibody that gave the strongest signalto-noise ratio in our hands. We chose rat antibodies H11, H22, H31, RH42, H53 and B66 for α1(IV) through α6(IV) respectively.
